There are two diabetes drugs that are being touted as miracle weight loss cures. Ozempic and Wegovy, both manufactured by Danish pharmaceutical company Novo Nordisk, are intended for the treatment of Type 2 diabetes. But people all over the world are trying to get their hands on it for its weight loss effects.
They work by sending messages to the brain that we’re full which increases insulin production which in turn lowers blood sugar. They also reportedly lowers food intake by lowering appetite and slowing down digestion in the stomach. Studies have found they reduce hunger, food craving, and in turn, body fat. No wonder they’ve been in such high demand.
These drugs have been so sought after that last year diabetics in Australia couldn’t get their hands on Ozempic because it was sold out across the country.
The stories about these new drugs are nothing short of astounding. But, as with all medications, they are not without their risks. This article takes a great look at the success stories and the side effects and then asks the ultimate question: if we have stumbled into a world of effective weight-loss drugs, how will that change how we think about being fat and being thin?
This is an excerpt from our Thought Starters email. Once a week we send you 5 interesting articles that have caught our attention, to get you thinking. No spam, we guarantee.